Matthew Hamilton Rosenberg’s Transcat TRNS Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio TRNS Stock Details TRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-800	Closed	-$52K	–	740
2021 Q3	$52K	Buy	+800	New	+$51K	0.02%	386

Other funds holding TRNS

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BAM

Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Matthew Hamilton Rosenberg's TRNS Position: Q4 2021 in Review

Matthew Hamilton Rosenberg sold out of Transcat (TRNS) in Q4 2021, closing a stake of 800 shares — an estimated $52K sold.

Matthew Hamilton Rosenberg first reported a position in TRNS in Q3 2021 and held it in 1 quarter. The position peaked at $52K in Q3 2021. 111 funds tracked by Wall St. Rank hold TRNS as of Q4 2021.

Matthew Hamilton Rosenberg reported no remaining Transcat position as of Q4 2021 after selling out during the quarter.
Matthew Hamilton Rosenberg sold 800 Transcat shares in Q4 2021, an estimated $52K.
Matthew Hamilton Rosenberg first reported a position in Transcat in Q3 2021 and held it in 1 quarter.
Matthew Hamilton Rosenberg's Transcat position peaked at $52K in Q3 2021.
111 funds tracked by Wall St. Rank held Transcat as of Q4 2021.

Based on Matthew Hamilton Rosenberg's 13F filing for Q4 2021, filed 20 Jan 2022.